Epix Plans To Appeal FDA Drug Decision
EPIX Pharmaceuticals Inc. said Friday that it plans to appeal a decision by the U.S. Food and Drug Administration denying approval of blood-pool imaging agent Vasovist....To view the full article, register now.
Already a subscriber? Click here to view full article